Table 2 Demographics and clinical characteristics according to having had contact with a general practitioner during follow-up
Contact with GP during follow-up | |||
|---|---|---|---|
Yes: n = 200 (42%) | No: n = 275 (58%) | p-value | |
Demographics | |||
Age at time of questionnairea, M (SD) | 71.2 (7.6) | 71.3 (7.4) | 0.78 |
Education levela | 0.76 | ||
Low | 66 (34.0) | 99 (36.7) | |
Intermediate | 76 (39.2) | 97 (35.9) | |
High | 52 (26.8) | 74 (27.4) | |
Marital Statusa | 0.07 | ||
Partner | 179 (90.9) | 233 (85.3) | |
No partner | 18 (9.1) | 40 (14.7) | |
Number of comorbiditiesa | 0.84 | ||
No comorbidities | 57 (29.1) | 83 (30.4) | |
1 comorbidity | 73 (37.2) | 105 (38.5) | |
≥ 2 comorbidities | 66 (33.7) | 85 (31.1) | |
Preferring more contact with GP during follow-upa | 27 (35.5) | 49 (64.5) | 0.20 |
Clinical characteristics | |||
Primary treatmenta | < 0.001 | ||
Surgery | 80 (40.0) | 73 (26.5) | |
Radiotherapy | 25 (12.5) | 41 (14.9) | |
Hormonal therapy | 29 (14.5) | 21 (7.6) | |
Radiotherapy and hormonal therapy | 31 (15.5) | 48 (17.5) | |
Active surveillance | 27 (13.5) | 63 (22.9) | |
Watchful waiting | 4 (2.0) | 5 (1.8) | |
Other/unknown | 4 (2.0) | 24 (8.7) | |
Time since diagnosis in yearsa, M (range) | 4.4 (1.8–7.8) | 4.3 (1.8–8.1) | 0.39 |
Tumor stagea | 0.003 | ||
I | 31 (16.2) | 79 (31.2) | |
II | 91 (47.6) | 105 (41.5) | |
III | 44 (23.0) | 47 (18.6) | |
IV | 25 (13.1) | 22 (8.7) | |